A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats.

Source:http://linkedlifedata.com/resource/pubmed/id/17089050

Download in:

View as

General Info

PMID
17089050